Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5724069, 12 pages
https://doi.org/10.1155/2017/5724069
Review Article

Antiangiogenic Therapy for Diabetic Nephropathy

1Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
2Department of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan

Correspondence should be addressed to Katsuyuki Tanabe; pj.ca.u-amayako@kebanat

Received 30 March 2017; Revised 16 May 2017; Accepted 13 June 2017; Published 1 August 2017

Academic Editor: Sebastian Oltean

Copyright © 2017 Katsuyuki Tanabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Katsuyuki Tanabe, Yasufumi Sato, and Jun Wada, “Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression,” International Journal of Molecular Sciences, vol. 19, no. 7, pp. 1859, 2018. View at Publisher · View at Google Scholar
  • Katharina Schlereth, Dieter Weichenhan, Tobias Bauer, Tina Heumann, Evangelia Giannakouri, Daniel Lipka, Samira Jaeger, Matthias Schlesner, Patrick Aloy, Roland Eils, Christoph Plass, and Hellmut G Augustin, “The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium,” eLife, vol. 7, 2018. View at Publisher · View at Google Scholar
  • Christoph Plass, Hellmut G. Augustin, Dieter Weichenhan, Tina Heumann, Patrick Aloy, Katharina Schlereth, Roland Eils, Tobias Bauer, Evangelia Giannakouri, Daniel Lipka, Samira Jaeger, and Matthias Schlesner, “The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium,” eLife, vol. 7, 2018. View at Publisher · View at Google Scholar
  • Kana Masuda, Katsuyuki Tanabe, Haruyo Ujike, Norikazu Hinamoto, Hiromasa Miyake, Satoshi Tanimura, Hitoshi Sugiyama, Yasufumi Sato, Yohei Maeshima, and Jun Wada, “Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model,” Plos One, vol. 13, no. 4, pp. e0195779, 2018. View at Publisher · View at Google Scholar
  • Shu-Zhi Wang, and Zheng-Hong Qin, “Anti-Inflammatory and Immune Regulatory Actions of Naja naja atra Venom,” Toxins, vol. 10, no. 3, pp. 100, 2018. View at Publisher · View at Google Scholar
  • Xianhong Li, Gangyi Chen, Baolin Su, and Shuifu Tang, “Effectiveness of antiplatelet drugs for the prevention of diabetic nephropathy: A meta-analysis of randomized controlled trials,” Clinical Nephrology, vol. 90, no. 6, pp. 419–426, 2018. View at Publisher · View at Google Scholar
  • Sona haku, Hiromichi Wakui, Kengo Azushima, Kotaro Haruhara, Sho Kinguchi, Kohji Ohki, Kazushi Uneda, Ryu Kobayashi, Miyuki Matsuda, Takahiro Yamaji, Takayuki Yamada, Shintaro Minegishi, Tomoaki Ishigami, Akio Yamashita, Kenichi Ohashi, and Kouichi Tamura, “ Early Enhanced Leucine-Rich α -2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice ,” BioMed Research International, vol. 2018, pp. 1–9, 2018. View at Publisher · View at Google Scholar
  • Sanna Lehtonen, “SHIPping out diabetes—Metformin, an old friend among new SHIP2 inhibitors,” Acta Physiologica, 2019. View at Publisher · View at Google Scholar
  • Satoshi Tanimura, Katsuyuki Tanabe, Hiromasa Miyake, Kana Masuda, Keigo Tsushida, Tomoyo Morioka, Hitoshi Sugiyama, Yasufumi Sato, and Jun Wada, “Renal tubular injury exacerbated by vasohibin-1 deficiency in a murine cisplatin-induced acute kidney injury model,” American Journal of Physiology-Renal Physiology, vol. 317, no. 2, pp. F264–F274, 2019. View at Publisher · View at Google Scholar
  • Michael Rauchman, and David Griggs, “Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis,” Translational Research, 2019. View at Publisher · View at Google Scholar
  • Wanning Wang, Weixia Sun, Yanli Cheng, Zhonggao Xu, and Lu Cai, “Role of sirtuin-1 in diabetic nephropathy,” Journal of Molecular Medicine, 2019. View at Publisher · View at Google Scholar
  • Min Xiang, Zhihong Chen, Liangping He, Guoliang Xiong, and Jiandong Lu, “Transcription profiling of artemisinin-treated diabetic nephropathy rats using high-throughput sequencing,” Life Sciences, 2019. View at Publisher · View at Google Scholar
  • ShaoBin Li, HeQin Zou, MinMin Gong, YuQin Chen, XiaoYong Yan, LiMei Yu, and YiBin Yang, “Angiopoietin-1 Promotes the Integrity of Neovascularization in the Subcutaneous Matrigel of Type 1 Diabetic Rats,” BioMed Research International, vol. 2019, pp. 1–11, 2019. View at Publisher · View at Google Scholar